{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-020309","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.595588+00:00","generated_at":"2026-06-14T07:03:52.177054+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Microbot Medical raises $1.5M via registered direct offering of 701,756 shares at $2.1375 each","bullets":["Gross proceeds of $1.5M from sale of 701,756 shares of common stock at $2.1375/share.","Concurrent private placement: Series C warrants to purchase up to 350,878 shares at $2.075, exercisable for 5.5 years.","H.C. Wainwright acted as placement agent, receiving 7% cash fee plus warrants for 35,088 shares.","Net proceeds to fund development and commercialization of LIBERTY Robotic System and working capital.","Offering closed on June 6, 2023 under shelf registration statement (File No. 333-250966)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-020309","json":"https://secwatch.observer/filing/0001493152-23-020309.json","markdown":"https://secwatch.observer/filing/0001493152-23-020309.md","text":"https://secwatch.observer/filing/0001493152-23-020309.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/0001493152-23-020309-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:03:52.177054+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cfcccdf962490ac6830d7be7473836ca9de87237","claim":"Microbot Medical Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2023-05-16).","evidence_excerpt":"On May 16, 2023 and in connection with the Offerings, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright agreed to serve as the exclusive placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/0001493152-23-020309-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Effective","value":"2023-05-16"}],"fact_type":"material_agreement"},{"claim_id":"ef1292de6b46d7ef3a510b8aca89215e51d9f934","claim":"Microbot Medical Inc. entered into Purchase Agreements with institutional investors valued at approximately $1.5 million (effective 2023-06-02).","evidence_excerpt":"On June 2, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into Securities Purchase Agreements (the “Purchase Agreements”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), an aggregate of 701,756 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $2.1375 per share, for aggregate gross proceeds from the Offerings (as defined below) of approximately $1.5 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/0001493152-23-020309-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional investors"},{"label":"Value","value":"approximately $1.5 million"},{"label":"Effective","value":"2023-06-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}